SW/PSYCH
Yelizaveta Sher, MD, FACLP (she/her/hers)
Psychiatry
Stanford University School of Medicine
Pasley Kimberly, PsyD (she/her/hers)
Nationwide Children's Hospital
While it has been known that the rates of depression and anxiety are 2 to 3 times higher in people with cystic fibrosis (CF), the community is now realizing that the rates of Attention Deficit Hyperactivity Disorder (ADHD) are also elevated. Untreated ADHD can contribute to decreased quality of life, distress, difficulty with medical adherence, and overall challenges in functioning. At the same time, it is important to accurately diagnose it considering its differential.
This timely symposium will discuss ADHD in both children and adults living with CF. It will discuss what ADHD is, how it presents, and how it is diagnosed in children and adults. It will highlight literature on ADHD in CF that has come out in recent years. It will further discuss particular characteristics of ADHD and its impact on a person’s neuropsychological functioning. The presenters will also address treatment, both with behavioral modifications and medications. Moreover, sleep in ADHD will be highlighted.
In addition, the symposium will touch on other neurocognitive concerns with people with CF, including due to aging, highly effective modulator therapy side effects, and post-transplantation.
Speaker: Lillian M. Christon, PHD (she/her/hers) – Medical University of South Carolina
Speaker: Mary Lynn Dell, MD, DMin, MHA (she/her/hers) – University of Virginia
Speaker: Yelizaveta Sher, MD, FACLP (she/her/hers) – Stanford University School of Medicine
Speaker: Aarti Shakkottai, MD, MS (she/her/hers) – UT Southwestern Medical Center